🏅 FDA Orphan Designation

RiaSTAP

human fibrinogen concentrate, pasteurized

Manufacturer: CSL Behring, LLC

Indicated for:

Congenital fibrinogen deficiencyOrphanFamilial afibrinogenemiaOrphanFamilial hypofibrinogenemiaOrphan

FDA-Approved Indications (3)

Congenital fibrinogen deficiencyOrphan Designation

Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia)

Familial afibrinogenemiaOrphan Designation

Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia)

Population: all ages

Familial hypofibrinogenemiaOrphan Designation

Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia)

Population: all ages

Indications & Usage

Treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency (afibrinogenemia and hypofibrinogenemia)

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.